Respiratory tract Flashcards

1
Q
  1. Infection of upper respiratory tract:

3 TYPES OF RHINITIS

A
  1. Allergic rhinitis
    - hay fever
    - allergic response, T1HR
  2. Infectious rhinitis
    - common cold
    - symptoms: catarrhal discharge, sneezing, sore throat, increased temperature
    - pathogens: rhino-, adeno-, echovirus etc
    - self limiting
    - complication: otitis media, sinusitis
  3. Chronic rhinitis
    - repeated acute rhinitis
    - serous exudate
    - more with a deviated septum or nasal polyps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Infection of upper respiratory tract:

SINUSITIS

A
  1. Acute sinusitis
    - from rhinitis
    - agent in oral cavity
    - non-specific inflammation
    - complication: empyema
  2. Chronic sinusitis
    - due to mixed microflora infection (bad-mucormycosis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. Infection of upper respiratory tract:

ACUTE PHARYNGITIS

A
  • symptoms: sore throat, red and edema of nasopharyngeal mucosa
  • cause: rhino-, echo- and adenovirus
  • more severe:
    • tonsillitis - s.pyogenes, s.aureus, adenovirus
    • herpangina - coxsackievirus A
    • mononucleosis - EBV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. Infection of upper respiratory tract:

TONSILLITIS

A
  • symptoms: sore throat, fever, enlarged and red tonsils, dotted exudate
  • cause: common cold viruses, s.pyogenes
  • chronic tonsillitis rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Infection of upper respiratory tract:

STREPTOCOCCAL TONSILLITIS COMPLICATIONS

A
  1. peritonsillary abscesses (quinsy)
  2. poststreptococcal glomerulonephritis
  3. acute rheumatic fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Infection of upper respiratory tract:

OTITIS MEDIA

A

= inflammation of middle ear due to dysfunction of Eustachian tube due to inflam. of nasopharynx
- can lead to hearing loss
- mostly young children
TYPES:
1. Acute otitis media
- blockage of Eustachian tube ⇒ buildup of air in middle ear
- cause: s.pneumonia, h.influenzae, moraxella catarrhalis
- diagnosis: non-infectious fluid in middle ear for more than 3 months
2. Otitis media with effusion
- generally no symptoms
- collection of fluid in middle ear
- cause: bacteria, virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. Infection of upper respiratory tract:

INFECTIOUS AGENTS

A
  1. Croup: Parainfluenza virus ⇒ laryngo-tracheo-bronchitis in children
  2. Diphteria: Corynebacterium ⇒ pseudomembrane
  3. Acute epiglottitis ⇒ H.influenzae
  4. Tonsillitis ⇒ Beta hemolytic strep
  5. Tuberculosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. Inflammation of trachea and larynx:

TRACHEITIS

A
  1. Bacterial tracheitis
    - cause: s.aureus, s.pneumonia, h.influenzae, m.catarrhalis
    - young children
    - can lead to airway obstruction
    - symptoms: coughing, insp. stridor, chest pain, fever, ear ache, headache, dizziness
  2. Decubitus
    - cause: long-term incubation
    - superficial, circumscribed, inflammatory and traumatic injury of mucosa + fibrin coverage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Inflammation of trachea and larynx:

LARYNGITIS

A

= inflammation of larynx ⇒ hoarse voice, complete loss of focal function

  • part of upper airway infection or exposure to toxins
    1. Acute Bacterial Epiglottitis
  • young children
  • h. influenzae
  • symptoms: pain + obstruction
    2. Acute Laryngitis
  • cause: inhalation of irritants, allergic reaction, common cold agents
  • Forms:
    • Tuberculosis laryngitis
    • Diphteritic laryngitis
      3. Laryngotracheobronchitis = croup
  • cause: parainfluenza virus
  • children
  • self-limited
  • symptoms: stridor, cough, airway narrowing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Diseases of vascular origin of the lung, atelectasis:

PULMONARY EMBOLISM, HEMORRHAGE AND INFARCTION

A
  • > 95% from deep vein thrombi
    CONSEQUENCES:
  • increase in pulmonary artery pressure
  • ischemia of downstream parenchyma
    MORPHOLOGY:
  • infarct: wedge shaped, apex towards hilum, hemorrhagic
  • early: raised, red-blue + fibrinous exudate
  • late: pale ⇒ red-brown with hemosiderin
  • histo: coagulative necrosis
    CLINICAL FEATURES:
  • 60-80% silent
  • 10-15% pulmonary infarction ⇒ dyspnea
  • 5% sudden death, acute cor pulmonale, cardiovascular collapse
  • 3% recurrent multiple emboli ⇒ pulmonary hypertension, chronic cor pulmonale, vascular sclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. Diseases of vascular origin of the lung, atelectasis:

RISK FACTORS FOR DEEP VEIN THROMBOSIS

A
  1. prolonged bedrest
  2. surgery
  3. severe trauma
  4. congestive heart failure
  5. partition or oral contraceptive use
  6. disseminated cancer
  7. primary disorders of hyper coagulability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Diseases of vascular origin of the lung, atelectasis:

CONSEQUENCES OF OCCLUSION OF MAJOR VESSEL

A
  1. sudden increase in pulmonary pressure
  2. decreased CO
  3. right sided heart failure
  4. hypoxemia
  5. death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Diseases of vascular origin of the lung, atelectasis:

PULMONARY HYPERTENSION

A
  • pressure: 1/4th or more of systemic pressure (normally 1/8)
  • secondary to decreased cross-sectional area or increased blood flow
    CAUSES:
  • chronic obstructive/interstitial lung disease
  • recurrent pulmonary emboli
  • antecedent heart disease
    PATHOGENESIS:
  • primary HT: BMPR-2 mutation⇒ abnormal monoclonal vascular endothelial and SM prolif., 5HTT mutation ⇒ proliferation due to serotonin
  • secondary HT: underlying disorder⇒ less vasodilatory agents
  • p. a. HT: VSCM dysfunction ⇒ fibrosis⇒ cor pulmonale
  • p. v. HT: left heart failure ⇒ pooling ⇒ pulmonary edema + effusions
    MORPHOLOGY:
  • intimal thickening and narrowing of the lumen
  • plexiform lesions
    CLINICAL FEATURES:
  • young adult, women
  • fatigue, syncope, dyspnea, chest pain
  • resp. insuff + cyanosis
  • needs lung transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. Diseases of vascular origin of the lung, atelectasis:

DIFFUSE ALVEOLAR HEMORRHAGE SYNDROMES

A
  • primary immune-mediated diseases
  • symptoms: hemoptysis, anemia, diffuse pulmonary infiltrates
    TYPES:
  • Goodpasture syndrome
  • Idiopathic pulmonary hemosiderosis
  • Wegener granulomatosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Diseases of vascular origin of the lung, atelectasis:

GOODPASTURE SYNDROME

A
  • proliferative, rapidly progressing glomarulonephritis + hemorrhagic interstitial pneumonitis
  • Type 2 HR ⇒ Antibodies against collagen 4
    RISK FACTORS:
  • HLA- DR15 gene
  • infections
  • smoking
  • oxidative stress
  • hydrocarbon-based solvents
    MORPHOLOGY:
  • heavy lungs, red-brown consolidations
  • focal necrosis, intra-alveolar hemorrhage, fibrous septal thickening, hypertrophic type 2 pneumocytes, hemosiderin
  • Ig deposits in glomerulus
    SYMPTOMS:
  • hematuria, proteinuria
  • nephritic syndrome
  • cough, hemoptysis
  • restrictive lung disease
    TREATMENT:
  • plasmaphoresis + immunosuppressive therapy
  • kidney transplant
    DIAGNOSIS:
  • kidney biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. Diseases of vascular origin of the lung, atelectasis:

IDIOPATHIC PULMONARY HEMOSIDEROSIS

A
  • rare; unknown etiology
  • occurs in children
    SYMPTOMS:
  • pulmonary same as Goodpasture
  • no kidney involvement or anti-basement membrane AB
    TREATMENT:
  • steroid + immunosuppressive therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
  1. Diseases of vascular origin of the lung, atelectasis:

WEGENER GRANULOMATOSIS

A
  • pulmonary angiitis + granulomatosis
  • rare
  • immune vasculitis
  • PR3-ANCAs
    SYMPTOMS:
  • pulmonary: patchy moving necrotizing vasculitis + parenchymal necrotizing granulomatous inflammation
  • cough, hemoptysis, chest pain
  • upper airway: sinusitis, epistaxis, nasal perforation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  1. Diseases of vascular origin of the lung, atelectasis:

ATELECTASIS

A

= incomplete expansion of lungs, or collapse of inflated lung
- prevent oxygenation + increases risk for infection
- reversible
TYPES:
1. Neonatal atelectasis
2. Aquired atelectasis
a. Resorption atelectasis:
- obstruction ⇒ oxygen trapped reabsorbed ⇒ alveolar collaps
- asthma, chronic bronchitis, bronchiectasis, postoperative state, foreign body aspiration, neoplasm
b. Compression atelectasis:
- congestive heart failure ⇒ pleural effusion
- pneumothorax
- ascites ⇒ elevated diaphragm ⇒ basal atelectasis
- mediastinum shifts away from atelectatic lung
c. Contraction atelectasis
- fibrotic changes in pleura/lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. Bronchial asthma, emphysema:

OBSTRUCTIVE AIRWAY DISEASE

A

= limited airflow due to increased resistance or complete obstruction
- normal FCV and decreased FEV1 ⇒ ratio FEV1:FCV decreased
DISORDERS:
- asthma
- emphysema
- chronic bronchitis
- bronchiectasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
  1. Bronchial asthma, emphysema:

RESTRICTIVE LUNG DISEASE

A

= decreased lung parenchyma expansion with decreased total lung capacity
- FCV decreased, FEV1 normal ⇒ FEV1:FCV normal
DISORDERS:
1. Chest wall disorders with normal lungs
- severe obesity
- pleural disease
- neuromuscular disorders
- respiratory muscle disease
2. Interstital lung disease
- ARDS
- pneumoconiosis, interstitial fibrosis, sarcoidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
  1. Bronchial asthma, emphysema:

BRONCHIAL ASTHMA

A

= chronic inflammatory disorder of airways. Obstructive lung disease
CAUSE:
- hygiene hypothesis
- respiratory infections, irritant exposure, cold air, stress, exercise
PATHOGENESIS:
- TH2 reaction ⇒ cytokines ⇒ inflammation
- recurrent inflam ⇒ hypertrophy of SM and mucus glands + increased vascularity + deposition of collagen
MORPHOLOGY:
- overinflation + atelectasis in lungs
- mucus plugs + Curschmann spirals + Charcot Leyden crystals
- thick wall + fibrosis + hypertrophy
CLINICAL FEATURES:
- asthma attack: dyspnea + wheezing + difficult expiration
TREATMENT:
- bronchodilators + corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
  1. Bronchial asthma, emphysema:

TYPES OF ASTHMA

A
  1. Atopic asthma
    - begins in childhood
    - Type 1 HR
    - allergic rhinitis, urticaria, eczema
    - triggers: environmental Ag, infections
    - diagnosis: Allergic skin test, serum radioallergosorbent tests
  2. Non-atopic asthma
    - no allergen sensitization
    - triggers: viral resp. infection, inhaled air pollutants
  3. Drug-induced asthma
    - aspirin!
    - rhinitis, nasal polyps, urticaria, bronchospasm
  4. Occupational asthma
    - triggers: fumes, organic dusts, gases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
  1. Bronchial asthma, emphysema:

EMPHYSEMA

A

= abnormal, permanent enlargement of airspace after terminal bronchioles with wall destruction
- obstructive lung disease
PATHOGENESIS:
- toxin exposure ⇒ inflammation with neutrophil, macrophage + lymphocytes ⇒ elastase, cytokines, oxidants ⇒ epithelial injury + proteolysis of ECM ⇒ loss of septa
- TGFB gene: regulate response to mesenchymal injury
- MMPs
MORPHOLOGY:
- Panacinar: pale, voluminous lungs, obscure the heart
- Centriacinar: deeper pink, less volume, deformed bronchioles
CLINICAL FEATURES:
- dyspnea (coughing + wheezing)
- weigth loss
- decreased FEV1:FCV ratio
- barrel chest
- death due to pulmonary failure or cor pulmonale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
  1. Bronchial asthma, emphysema:

TYPES OF EMPHYSEMA

A
  1. Centriacinar emphysema
    - respiratory bronchiole
    - both emphysematous + normal air spaces in same acinus
    - upper lobes
    - associated with tobacco
  2. Panacinar emphysema
    - acini uniformly enlarged, resp bronchioles to terminal alveoli
    - lower lung areas
    - associated with alpha1-antitrypsin deficiency
  3. Distal acinal emphysema
    - worse next to pleura, along lobular CT septa + margins of lobules
    - next to fibrosis, scarring + atelectasis
    - upper lobes
    - unknown cause
  4. Irregular emphysema
    - acinus irregularly involved
    - associated with scarring
    - asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q
  1. Chronic bronchitis, bronchiectasis, cystic fibrosis:

CHRONIC BRONCHITIS

A
  • obstructive lung disease
  • associated with smoking or pollution
  • persistent cough for 3 months in 2 years
    PATHOGENESIS:
  • hyper secretion of mucus
  • toxins ⇒ hypertrophy of mucus glands ⇒ increased goblet cells
  • airway obstruction: goblet cell metaplasia + mucus plug + inflammation + wall fibrosis, coexistent emphysema
    TYPES:
  • simple
  • asthmatic
  • obstructive
    MORPHOLOGY:
  • hyperemic and swollen mucosal lining + mucopurulent secretion
  • goblet cell metaplasia, mucus plugging, inflammation, fibrosis
  • REID index: gland layer to wall ratio, normal 0,4
    CLINICAL FEATURES:
  • hypercapnia, hypoxemia, cyanosis
  • often also emphysema
  • complications: pulmonary HT, cardiac failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q
  1. Chronic bronchitis, bronchiectasis, cystic fibrosis:

BRONCHIECTASIS

A

= permanent dilation of bronchi due to destruction of muscle and elastic tissue
- obstructive lung disease
PATHOGENESIS:
- obstruction ⇒ blocks normal clearance ⇒ infection
- chronic infection ⇒ weakening + dilation of walls
MORPHOLOGY:
- lower lobes on both sides
- dilated up to 4x
- active: inflammatory exudate in walls, ulceration
- chronic: peribronchiolar fibrosis, wall fibrosis
- abscess cavity ⇒ aspergilloma formation
CLINICAL FEATURES:
- cough, mucopurulent sputum, hemoptysis
- symptoms are episodic
- clubbing of fingers
- hypoxemia, hypercapnia, HT, cor pulmonale, metastatic brain abscess, reactive amyloidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q
  1. Chronic bronchitis, bronchiectasis, cystic fibrosis:

PREDISPOSING CONDITIONS TO BRONCHIECTASIS

A
  1. Broncial obstruction
    • tumors, foreign bodies, mucus plug
  2. Congenital condition
    - cystic fibrosis
    - immunodeficiency states
    - Kartagener syndrome (AR disorder, bronchiectasis + male sterility)
  3. Necrotizing pneumonia
    - associated with virulent organisms
    - posttuberculosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q
  1. Diffuse alveolar damage, pneumoconiosis:

DIFFUSE ALVEOLAR DAMAGE DAD

A
- restrictive lung disease
= histological patterns of ARDS
PATHOGENESIS:
 - Alveolar capillary membrane injury ⇒ direct (pneumonia or aspiration of gastric content) or indirect (sepsis, severe trauma) ⇒ hyaline membrane + loss of diffusion capacity + surfactant abnormalities
MORPHOLOGY:
 1. Acute phase
  - dark red, firm, airless, heavy
  - congestion, necrosis, edema, hemorrhage
  - hyaline membrane
 2. Organized phase
  - profile of type 2 pneumocytes
  - organization of fibrin exudate⇒ thick alveolar septa
CLINICAL FEATURES:
 - 40% mortality with treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q
  1. Diffuse alveolar damage, pneumoconiosis:

PNEUMOCONIOSIS

A
  • restricitve lung disease
  • occupational disease, inhalation of dust
    PATHOGENESIS:
  • reaction to dust depend on: size, shape, solubility, reactivity of the particles
  • particles trapped in alveolar bifurcations ⇒ macrophage accumulation + endocytosis ⇒ release inflammatory mediators ⇒ fibroblast proliferation and collagen deposition
    MINERAL DUSTS:
  • coal dust
  • silica
  • asbestos
30
Q
  1. Diffuse alveolar damage, pneumoconiosis:

COAL WORKER PNEUMOCONIOSIS

A
- coal= carbon + trace metals + inorganic minerals + crystalline silica
MORPHOLOGY:
 1. Pulmonary antracosis
   - inhaled carbon pigment engulfed by macrophages ⇒ accumulates in CT along lymphatics or in LN
   - benign + no change in lung function
 2. Simple CWP
   - coal macules + coal nodules
   - upper zones of lungs
   - centrilobular emphysema
 3. Complicated CWP
   - melding of coal nodules
   - black scars >2cm
   - histo: dense collagen + pigment
   - pulmonary dysfunction, HT and cor pulmonale
31
Q
  1. Diffuse alveolar damage, pneumoconiosis:

SILICOSIS

A

CAUSE:
- inhalation of crystalline silica (toxic + fibrinogenic)
PATHOGENESIS:
- silica + macrophage ⇒ activation + release of mediators⇒ fibrinogenesis
- silicotic nodule: concentrally arranged hyalinized collagen fibers with amorphous center
MORPHOLOGY:
- fibrotic nodules + massive fibrosis alveolar proteinosis
- detect via chest radiograph
- susceptibility to tuberculosis

32
Q
  1. Diffuse alveolar damage, pneumoconiosis:

ASBESTOSIS

A
CAUSE:
 - asbestos: crystalline hydrate silicates with fibrous geometry
PATHOGENESIS:
 - inhalation ⇒ macrophage ⇒ fibrosis
 - tumor initiator and promoter
MORPHOLOGY:
 - parenchymal interstitial fibrosis
 - localized fibrous plaques
 - pleural effusions
 - bronchogenic carcinoma
 - pleural and peritoneal mesothelioma
 - laryngeal carcinoma
 - Asbestos bodies: gold brown beaded rods with translucent center
 - begin in lower lobes and move upward
 - honeycomb appearance
33
Q
  1. Pulmonary infections:

CLASSIFICATION OF PNEUMONIA

A
  1. Clinical data: acute / chronic
  2. Histological spectrum
    • fibrinopurulent alveolar exudate
    • mononuclear interstitial infiltrates
    • granulomas and cavitations
  3. Patterns
    • bronchopneumonia
    • lobar pneumonia
  4. Clinical feature: atypical / hypostatic
  5. Type of infection: community / nosocomial / opportunistic
  6. Based on agents: bacterial / viral / fungal
  7. Based on host: normal / immunocompromised
34
Q
  1. Pulmonary infections:

COMMUNITY-ACQUIRED PNEUMONIA

A
SYMPTOMS:
 - high fever, shaking chills, chest pains, productive mucopurulent cough, hemoptysis
CAUSE:
 - S.pneumoniae 
   ⇒ people with chronic diseases
   ⇒ people with immunoglobulin defect
   ⇒ people with decreased/absent splenic function
MORPHOLOGY:
 - lobar or broncho pneumonia
 - lower or right middle lobe
COMPLICATIONS:
 - abscess formation
 - empyema
 - scarring
 - dissemination ⇒ meningitis, arthritis, infective endocarditis
DIAGNOSIS:
 - sputum + gram staining
35
Q
  1. Pulmonary infections:

LOBAR PNEUMONIA STAGES

A
  1. Congestion
    - heavy, red and boggy lobes
    - vascular congestion, proteinaceous fluid, neutrophils + bacteria in alveoli
  2. Red Hepatization
    - within few days
    - liver like consistency
    - alveolar spaces packed with neutrophils, RBCs and fibrin
  3. Grey Hepatization
    - dry, grey and firm
    - fibrinosuppurative exudate in alveoli
  4. Resolution
    - exudates enzymatically digested ⇒ granular, semi-fluid debris ⇒ macrophages
    - pleural reaction ⇒ fibrous thickening
36
Q
  1. Pulmonary infections:

BRONCHOPNEUMONIA morphology

A
  • 3-4cm wide, grey-yellow elevated lesions

- focal suppurative exudate that fills bronchi, bronchioles and alveoli

37
Q
  1. Pulmonary infections:

LEGIONELLA PNEUMONIA

A
  • causes: Legionnaire’s disease + Pontiac fever
  • source: water cooling tower, air-conditioning system, water pipes
  • transmission: inhalation or aspiration of contaminated water
  • risk factors: smoking, renal failure, obstructive pulmonary disease, diabetes
38
Q
  1. Pulmonary infections:

ORGANISMS CAUSING COMMUNITY-ACQUIRED PNEUMONIA

A
  1. H. influenza ⇒ pneumonia in children
  2. M. catarrhalis ⇒ elderly, otitis media in children
  3. S.aureus ⇒ secondary bacterial pneumonia
  4. K.pneumoniae ⇒ debilitated and malnourished people
  5. P. aeruginosa ⇒ nosocomial
39
Q
  1. Pulmonary infections:

COMMUNITY ACQUIRED ATYPICAL PNEUMONIA

A
CAUSATIVE AGENTS:
 - Mycoplasma pneumoniae
 - Chlamydia pneumoniae
 - Coxiella burnetti 
 - viruses
PATHOGENESIS:
 - attachment of organism to resp. epith. ⇒ necrosis of cells ⇒ inflammatory response ⇒ damage to mucociliary clearance ⇒ secondary bacterial infection risk 
MORPHOLOGY:
 - affected areas red-blue + congested
 - inflammatory reaction inside alveoli
 - alveolar spaces are free of cellular exudates
CLINICAL FEATURES:
 - fever, headache, malaise
 - cough + little sputum
40
Q
  1. Pulmonary infections:

NOSOCOMIAL PNEUMONIA

A
  • hospital aquired
  • in patients with underlying disease, immune suppression or prolonged antibiotic therapy
    CAUSATIVE AGENTS:
  • enterobacteriaceae
  • pseudomonas spp
  • s.aureus
41
Q
  1. Pulmonary infections:

ASPIRATION PNEUMONIA

A
  • occurs in debilitated patients or those who aspirate gastric content
  • partially chemical, partially bacterial
  • abcess formation common
    CAUSATIVE AGENTS:
  • anaerobic oral flora
  • s.pneumonia
  • s.aureus
  • h.influenzae
  • p.aerginosa
42
Q
  1. Pulmonary infections:

LUNG ABCESS

A
= collection of pus in a cavity. Result of body's defense reaction to foreign material or pathogen
TRANSMISSION:
 - aspiration of infective material
 - aspiration of gastric content
 - complication of necrotizing bacterial pneumonia
MORPHOLOGY:
 - 1mm-6cm
 - more common on right side
 - tend to rupture into airways ⇒ bronchopleural fistula ⇒ pneumothorax or empyema
CLINICAL FEATURES:
 - prominent cough
 - smelly, purulent or bloody sputum
 - malaise, spiking fevers
43
Q
  1. Pulmonary infections:

CHRONIC PNEUMONIA

A
  • localized lesions in immunocompetent person. LN involvement
  • granulomatous inflammation
    CAUSATIVE AGENTS:
  • nocardia
  • actinomyces
  • mycobacterium tuberculosis
  • histoplasma capsulatum, coccidioides immitis, blastomyces dermatitidis
44
Q
  1. Pulmonary infections:

OPPORTUNISTIC INFECTIONS

A
  1. Candida albicans
    - part of normal flora in oral cavity, GI, vagina
    - Candidasis ⇒ mucus membrane, skin, deep organs
  2. Aspergillus
    - invasive aspergillosis ⇒ pneumonia
    - aspergilloma= fungal balls with micro abscesses
  3. Cytomegalovirus
  4. Pneumocystis jiroveci
  5. Mycobacterium avium
45
Q
  1. Pulmonary hypertension, pleural lesions:

PLEURAL EFFUSION AND PLEURITIS

A
  1. Transudate ⇒ hydrothorax
    - increased fluid pressure or decreased colloid oncotic pressure
    - cause: CHF
    ⇒ resorbed
  2. Exudate
    - cause: suppurative pleuritis, cancer, pulmonary infarction, viral pleuritis
    ⇒ fibrinous organization
    TREATMENT:
    - drainage
46
Q
  1. Pulmonary hypertension, pleural lesions:

PNEUMOTHORAX

A
TYPES:
 1. Spontaneous pneumothorax
 2. Secondary pneumothorax (lung ot thoracic disorder)
 3. Traumatic pneumothorax (injury)
COMPLICATIONS:
 1. Tension pneumothorax
 2. Infection
 3. Empyema (pyopneumothorax)
47
Q
  1. Pulmonary hypertension, pleural lesions:

HEMOTHORAX

A

= accumulation of whole blood in the pleural cavity

- usually complication of ruptured intrathroacic aortic aneurysm

48
Q
  1. Pulmonary hypertension, pleural lesions:

CHYLOTHORAX

A

= pleural collection of milky lymphatic fluid containing micro globules of lipid
- implies obstruction of major lymph duct, usually intrathoracic cancer

49
Q
  1. Pulmonary hypertension, pleural lesions:

MALIGNANT MESOTHELIOMA

A
  • rare cancer of mesothelial cells
  • in parietal or visceral pleura, also peritoneum and pericardium
  • cause: asbestos
  • latent period: 25-40 years
    MORPHOLOGY:
  • pleural fibrosis and plaque formation
  • begin in localized area ⇒ spread widely
  • yellow-white firm gelatinous layer of tumor on top of lung
  • rarely metastasize
50
Q
  1. Tumors of nasal passages, nasopharynx and larynx:

NASOPHARYNGEAL CARCINOMA

A
ETIOLOGY:
 - strong links to EBV
 - Africa ⇒ common childhood cancer
 - China ⇒ common adult cancer, 70% male
PATHOGENESIS:
 - EBV replicate in mucosal nasopharyngeal epithelium ⇒ infect B cells of tonsils
MORPHOLOGY:
 - 3 histological subtypes:
  1. well differentiated keratinizing squamous carcinoma
  2. moderately differentiated non-keratinizing squamous c
  3. undifferentiated type
 - spread to cervical LN, metastasize to distant sites
TREATMENT:
 - immunotherapy
 - radiotherapy
 - chemotherapy
 - 5 year survival 50%
51
Q
  1. Tumors of nasal passages, nasopharynx and larynx:

VOCAL CORD POLYPS

A
  • smooth, hemispherical protruding mass of tissue
  • location: true vocal cords
  • nodules composed of fibrous tissue and covered by strat. squamous mucosa
  • cause: smoking, singing
52
Q
  1. Tumors of nasal passages, nasopharynx and larynx:

LARYNGEAL PAPILLOMA

A
  • benign neoplasm
  • location: true vocal cords
  • do not become malignant ⇒ often spontaneously regress
  • complication: trauma ⇒ ulceration + hemoptysis
  • children: recurrent respiratory papillomatosis (HPV 6 and 11, vertical transmission)
  • adults: solitary papillomas, usually in men
  • Differential diagnosis: verrucous carcinoma
53
Q
  1. Tumors of nasal passages, nasopharynx and larynx:

CARCINOMA OF THE LARYNX

A
- after age 40, more in men 7:1
CAUSE:
 - smoking
 - alcohol
 - asbestos
 - HPV
-95% squamous cell carcinoma
LOCATION:
 - 60-75% glottic tumors
 - 25-40% supraglottic
 - <5% subglottic 
GROWTH PATTERN:
 - in situ lesion ⇒ pearly grey, wrinkled plaque ⇒ ulcerated and necrotized
TREATMENT:
 - surgery, radiation, combined therapy
54
Q
  1. Tumors of nasal passages, nasopharynx and larynx:

TUMORS OF THE NASAL PASSAGES

A
  • squamous cell carcinoma
  • adenocarcinoma
  • malignant melanoma
  • inverting papilloma
  • esthesioneuroblastoma
  • midline granuloma
  • lymphoma
  • sarcoma
55
Q
  1. Benign and metastatic tumors of lung:

HAMARTOMA

A
  • excessive focal overgrowth of cells and tissues native to the organ ⇒ completely benign
  • grows in a disorganized mass within normal tissue
  • arise from CT
  • can compress surrounding tissue
56
Q
  1. Benign and metastatic tumors of lung:

ADENOMAS

A
  • adenomas in the bronchi
  • arise from mucous glands and ducts of the trachea or bronchi
  • types: alveolar, bronchial gland, papillary, pleomorphic
57
Q
  1. Benign and metastatic tumors of lung:

SOLITARY FIBROUS TUMOR

A
  • rare mesenchymal tumor in pleura
  • can be very large
  • usually asymptomatic
  • Treatment: surgical resection
58
Q
  1. Benign and metastatic tumors of lung:

DESMOID TUMOR

A
  • benign slow growing soft tissue tumor

- infiltrative, well-differentiated, firm overgrowth of fibrous tissue

59
Q
  1. Benign and metastatic tumors of lung:

CARCINOID TUMOR

A
  • slow growing neuroendocrine tumor
  • bronchial carcinoids arise fron Kichitsky cells
  • contain dense-core neurosecretory granules
60
Q
  1. Benign and metastatic tumors of lung:

SCLEROSING HEMANGIOMA

A
  • arise from incompletely differentiated resp. epith.
  • asymptomatic, peripheral, solitary, well circumscribed
  • women around 50 years
  • metastasis: regional LN
  • histo: surface + round cells
    ⇒ papillary, sclerotic, solid or hemorrhagic
  • treatment: surgical excision
61
Q
  1. Benign and metastatic tumors of lung:

METASTATIC TUMORS

A
  1. breast carcinoma
  2. colorectal carcinoma
  3. renal cell carcinoma
  4. uterine leiomyosarcoma
  5. head and neck squamous cell carcinoma
  6. malignant melanoma
  7. sarcoma
  8. lymphoma + leukemia
  9. germ cell tumors
62
Q
  1. Benign and metastatic tumors of lung:

METASTASIS FROM LUNGS

A
  1. LN
  2. hematogen
  3. brain
  4. bone
  5. liver
  6. adrenal gland
  7. skin
  8. serous membrane
  9. other lung
63
Q
  1. Malignant lung tumors:

LUNG CARCINOMAS

A
RISK FACTORS
 - smoking
 - carcinogens
 - radiation therapy
 - recurrent inflammation
 - talc + talcpowder
SYMPTOMS:
 - dyspnea, coughing, weight loss
- age: 50-60 
- 5 year survival ⇒ 15%
CLASSIFICATION:
2 therapeutic types:
 - small cell lung cancer SCLC
 - non-small cell lung cancer NSCLC
4 histological types:
 - squamous cell carcinoma
 - adenocarcinoma
 - small-cell carcinoma
 - large-cell carcinoma
 - combined patterns
MORPHOLOGY:
 - firm and grey-white small lesions
 - intraluminal masses, invade bronchial mucosa or bulky masses pushing adjacent lung parenchyma
 - central necrosis + hemorrhage
 - virchow node involvement
64
Q
  1. Malignant lung tumors:

SCLC vs. NSCLC

A

SCLC:

  • neuroendocrine cells, anaplastic cells
  • risk factor: smoking
  • origin: Kulschitzky cells, stem cells
  • therapy: chemo - + radiation therapy
  • RB mutation

NSCLC:

  • squamous epith cell, adenocarcinoma, large cell carcinoma
  • risk factor: smoking
  • origin: scc- metaplasia, adc- pneumocyte 2, stem cells
  • therapy: surgery
  • inactive p16/CDKN2A
65
Q
  1. Malignant lung tumors:

SQUAMOUS CELL CARCINOMA

A
  • more common i men, age 40
  • related to smoking
  • arise centrally in major bronchi ⇒ spread to local lymph nodes
  • preneoplastic lesion ⇒ carcinoma in situ
  • histo: well differentiated squamous neoplasm with keratin pearls and intracellular bridges - poor differentiated with minimal residual features of squamous cell
66
Q
  1. Malignant lung tumors:

ADENOCARCINOMA

A
  • malignant form originating from glandular tissue or produced a glandular pattern
  • some have mutation in EGFR
  • can be central lesions or in the periphery
  • grow slowly and form smaller masses
  • metastasize a lot in early stage
  • forms: acinar, papillary and solid
  • precursor lesion: adenomatous hyperplasia AAH
67
Q
  1. Malignant lung tumors:

SMALL CELL CARCINOMA

A
  • pale grey, centrally located masses, send extensions into lung parenchyma
  • early involvement of hilar and mediastinal LN
  • cells: round-fusiform, little cytoplasm, finely granular chromatin, mitotic figures
  • precursor lesions: neuroendocrine cells (Kulschitzky cells)
  • cause paraneoplastic syndromes
68
Q
  1. Malignant lung tumors:

LARGE-CELL CARCINOMA

A
  • undifferentiated malignant epithelial tumors
  • no cytological features like small cell carcinoma, no glandular or squamous diff.
  • cells: large nuclei, prominent nucleoli, moderate amount of cytoplasm
69
Q
  1. Malignant lung tumors:

PANCOAST TUMORS

A
  • location: pulmonary apex
  • type: non-small cell lung cancer
  • clinical relevance: compress cervical sympathetic ganglion ⇒ Horner syndrome:
    ⇒ ptosis: drooping of eyelid
    ⇒ miosis: constriction of pupil
    ⇒ enophthalmus: sunken in eyes
    ⇒ anhidrosis: no sweating
    + pain in distribution of ulnar nerve
    + destruction of 1st and 2nd ribs
70
Q
  1. Malignant lung tumors:

CARCINOID TUMORS

A

= malignant tumors made of cells containing neurosecretory granules
CLASSIFICATION:
1. typical low grade:
- uniform cells with regular round nuclei + salt and pepper chromatin
2. atypical intermediate grade:
- higher mitotic rate + focal necrosis
- more LN and distal metastases
- p53 mutations
ETIOLOGY:
- men around 40 years
MORPHOLOGY:
- originate in main bronchi
- growth patterns:
1. obstructing, polyploid, spherical, intraluminal masses
2. mucosal plaque, penetrates bronchial wall⇒ collar-button lesion
- metastasize to hilar LN
- result in small cell carcinoma
CLINICAL FEATURES:
- asymptomatic
- cough, hemoptysis, infection
- carcinoid syndrome: diarrhea, flushing, cyanosis

71
Q
  1. Malignant lung tumors:

PARANEOPLASTIC SYNDROMES

A

3-10%

  1. PTH related peptide ⇒ hypercalcemia
  2. ACTH ⇒ Cushing syndrome
  3. inappropriate ADH secretion
  4. neuromuscular syndromes
  5. clubbing of fingers + hypertrophic pulmonary osteoarthropathy
  6. hematological manifestations: DIC, migratory thrombophlebitis